Radioligand therapies harness the cytotoxic force of radiotherapy with molecular precision—emerging as a new strategy for cancers. Clinical-stage radioligand therapies landscape overview #ASCO25 nature.com/articles/d4157…

We're proud to join Chimeric Therapeutics ASX: CHM to announce that CAR T-Cell Therapy has a Fast-Track designation by the FDA as a potential new treatment for GEP-NETs. Learn more. netrf.org/2025/06/04/car…

Chimeric Therapeutics gains FDA fast-track approval for CHM CDH17 gastrointestinal cancer candidate | Media coverage by Small Caps. smallcaps.com.au/chimeric-thera… $CHM #Chimeric #SmallCaps #Biotech #ASXNews

Dr. Mauro Cives Mauro Cives : “Cancer vaccines are investigated also in the NEN field.” ✔️Watch this valuable presentation on translational NEN research to learn what the future holds: incalliance.org/dr-mauro-cives… ✔️Find active NET clinical trials here: incalliance.org/find-a-trial/

📢 The deadline for the BTSI award has been extended to June 23rd, so there's more time to submit your NEN-focused applications! Thanks to NANETS & NET Research Foundation for sponsoring the award.

I still get excited about good clinical papers! 😀I have been waiting for this one with much anticipation... For anyone taking care of patients with MEN1 or interested in learning more, this is the document you need. Kudos to the team that got this done including Mark Lewis, MD, FASCO !

Dr. Mauro Cives Mauro Cives : “By exploring new NEN models, we will be able to test treatments in vitro before administering that specific treatment to a patient.” ☑️Watch the video to find out the advancements in NEN research: incalliance.org/dr-mauro-cives… #LetsTalkAboutNETs

🔊🔊 Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors 🙌🏼 A new treatment option for ALL NET patients!! 👏🏼 ⁦Grupo GETNE⁩ ⁦NET- ESPAÑA⁩ ⁦NET Research Foundation⁩ ipsen.com/press-releases…

🔶Dr. Mauro Cives Mauro Cives : “Single-cell and single-nuclei sequencing technologies will help researchers in gaining a better understanding of the biology of neuroendocrine neoplasms”. 📱Watch the video with the latest on translational NEN research: incalliance.org/dr-mauro-cives…

Almost hereee! I hope you all enjoy listening as much as I enjoyed recording! Launching July 7th! 🎧🎙️

I try, often unsuccessfully, to not post while on vacation but this is just too important. Hot of the Arvind Dasari, MD, MS et al. press. New SEER data. Increasing incidence and prevalence, owing to earlier and likely largely incidental diagnoses. Improving OS too🙂 jamanetwork.com/journals/jaman…

New NETRF-supported research is advancing our understanding of metastatic neuroendocrine tumors. Genome analysis uncovered that different parts of the body can share molecular features and genetic clues that may guide future treatments. Learn more: netrf.org/2025/06/26/met…

📱Watch the video with the latest on translational NEN research by Dr. Mauro Cives Mauro Cives – now with captions in French, German, Italian, Portuguese and Spanish: incalliance.org/dr-mauro-cives… #LetsTalkAboutNETs #MedTwitter #OncTwitter #OncoTwitter

💻Check out our collections of video presentations by prominent NEN researchers to be abreast of the latest in NEN clinical trials: incalliance.org/researcher-ins… 🌎Available in English with captions in French, German, Italian, Portuguese and Spanish. #LetsTalkAboutNETs #OncTwitter

Dr. Mauro Cives Mauro Cives: “In the future, we will be able to understand what the differences are between cells that can metastasize and the cells that are not able to.” 📱Watch the video with Dr. Mauro Cives – now with captions in 5 languages: incalliance.org/dr-mauro-cives…

Hot off the presses, probably my favorite interventional paper of 2025 (doesn't hurt that I look up to several of the authors as mentors or role models). 💉RAS vaccination is starting to look less like fantasy, more like reality. 🆕 Nature Medicine | Wainberg et al 🎯